STAT
AUGUST 30, 2023
Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may be unnecessarily disenrolling children from Medicaid or the Children’s Health Insurance Program because they are reviewing families as a whole despite there being a higher threshold to remove children from the programs.
PharmaVoice
AUGUST 30, 2023
Experts have determined the strains of this year’s flu season — now the question is whether people are too fatigued by the pandemic to be immunized.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 30, 2023
Amid controversy over access to a lifesaving tuberculosis pill, a new contracting effort is expected to lower the price for the medicine by as much as 55% in dozens of low- and middle-income countries, according to a group that administers a global fund for distributing TB drugs. But advocacy groups continue to argue that Johnson & Johnson, which makes the pill, has stymied wider access.
PharmaVoice
AUGUST 30, 2023
The list of blockbuster cardiovascular, diabetes and cancer drugs gives the industry a window into how regulators are approaching price negotiations.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
AUGUST 30, 2023
A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role. A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic.
The Pharmacist
AUGUST 30, 2023
Community pharmacies will get additional payments to deliver Covid vaccinations in September and October as the government brings forward the autumn programme in light of a new Covid variant. But the sector’s negotiator has criticised the government’s ‘shambolic start’ to the vaccination programme, which it said has a ‘seemingly endlessly changing timetable’ that leaves community […] The post CPE slams 'shambolic' vaccination U-turn despite additional funding appeared first on Th
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
AUGUST 30, 2023
This autumn's Covid vaccination programmes in England are being brought forward to begin on 11 September following the identification of a new Covid variant, the government has announced. Eligible patients are being urged to come forward for their jab as soon as they are invited to do so, with NHS England prioritising those living in […] The post Breaking: Autumn jabs brought forward amid new Covid variant appeared first on The Pharmacist.
STAT
AUGUST 30, 2023
SANTA MONICA, Calif. — Where Laurel Braitman is sitting is rather apt. Braitman, whose first book, “Animal Madness,” won her fans and TED Talk acclaim, is unmistakable in a fringed, cream-colored jacket and thick, square glasses, perched on a tall chair near the back of Zibby’s Bookshop. It’s a small, airy paperback oasis along a bougie stretch of cafés and day spas.
Express Pharma
AUGUST 30, 2023
A research team from Japan developed an innovative methodology to detect Lipopolysaccharide (LPS). Based on a novel fluorescent chemosensor, the proposed system detects the endotoxin in a matter of minutes, making it suitable for on-site testing in hospitals and pharma manufacturing facilities. LPS, largely known as “endotoxins”, is a molecule which is found in the outer membrane of Gram-negative bacteria, and can be very harmful to humans.
STAT
AUGUST 30, 2023
On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. K RAS, one of the most common genetic mutations in cancer, has been one of the most tantalizing oncogenic targets for drug developers since its discovery four decades ago. An altered KRAS gene can drive cells to divide uncontrollably, propelling them down the path towards malignancy.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Pharmacist
AUGUST 30, 2023
The number of advanced pharmacist practitioner roles in general practice in England has nearly doubled in the last year, while the number of pharmacists has remained consistent. The increase in advanced roles has brought the total number of full-time equivalent (FTE) pharmacist roles in general practice to 2,000 as of July 2023, once both roles […] The post Number of advanced pharmacist roles in general practice doubles in a year appeared first on The Pharmacist.
STAT
AUGUST 30, 2023
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is … cinnamon sticky bun.
The Pharmacist
AUGUST 30, 2023
With varenicline currently unavailable, is it possible that cytisine might serve as an alternative pharmacotherapy to help patients to stop smoking? Rod Tucker takes a closer look in our Review series. Tobacco smoking is a major cause of premature death and kills more than eight million people each year, including 1.3 million non-smokers, exposed to […] The post Could cytisine replace varenicline for smoking cessation?
European Pharmaceutical Review
AUGUST 30, 2023
According to a report by Transparency Market Research Inc, the global cell and gene therapy (CGT) manufacturing quality control (QC) market is anticipated to value $2.8 billion in 2031. It is projected to expand at a CAGR of 24.6 percent from 2023 to 2031. Comparatively, the market is expected to value $463.1 million by the end of 2023. With increasing research and development in the cell and gene therapy field, the demand for optimal quality control is needed to ensure the safe and efficient ma
Express Pharma
AUGUST 30, 2023
HEAL Health recently organised a webinar titled ‘Demystifying the NMC Guidelines Conundrum’ against the backdrop of the recent postponement of the National Medical Commission (NMC) guidelines. The insights that emerged encompassed a spectrum of perspectives, shedding light on intricate challenges and potential solutions. Prof (Dr) J A Jayalal, Secretary General, Commonwealth Medical Association & Former National President, IMA , asserted, “An act perceived as draconian has gal
The Pharmacist
AUGUST 30, 2023
Middle-aged people who have three or more ‘unhealthy’ traits have heart attacks and strokes two years sooner, highlighting the importance of screening and early detection, say Swedish researchers. Those classed as having metabolic syndrome – with a slightly high waist circumference, and marginally increased blood pressure, cholesterol and glucose levels – but who otherwise feel […] The post Slightly unhealthy middle aged traits linked with earlier heart attacks and strokes appeared first o
Express Pharma
AUGUST 30, 2023
Ajanta Pharma has received final approval from the United States Food and Drug Administration (USFDA) to market Topiramate Extended-Release Capsules, 25 mg, 50 mg, 100 mg and 200 mg. Topiramate is the generic version of Supernus Pharmaceuticals Inc’s Trokendi XR. As per the settlement with the innovator, Ajanta can launch Topiramate on February 1, 2026 or earlier under certain circumstances.
BioPharma Dive
AUGUST 30, 2023
The acquisition of Embark Biotech, which Novo helped found, gives the company another prospect to add to its arsenal of weight-loss medicines.
Pharmaceutical Technology
AUGUST 30, 2023
Biostax and Immgenuity have entered into an agreement to expedite the development of new immunotherapeutics to treat HIV and other diseases.
Pharmaceutical Commerce
AUGUST 30, 2023
Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.
Express Pharma
AUGUST 30, 2023
Amneal Pharmaceuticals announced that a delegation of senior members of the US Department of Health and Human Services (HHS) and US Food and Drug Administration (FDA) together with local government officials recently visited the Company’s manufacturing facility in Matoda, India. The visit followed the G20 Health Ministers’ meeting in Gandhinagar, India on August 18 and 19, where health ministers from around the world met to discuss global health issues.
Pharma Times
AUGUST 30, 2023
The therapy involves treating individuals with atherosclerotic cardiovascular disease - News - PharmaTimes
Pharmaceutical Technology
AUGUST 30, 2023
The US FDA has granted priority review for Zealand Pharma’s dasiglucagon for hypoglycemia in the infants with congenital hyperinsulinism.
Pharma Times
AUGUST 30, 2023
Funding will progress the manufacture of oligonucleotide therapeutics alongside machine learning - News - PharmaTimes
Pharmaceutical Technology
AUGUST 30, 2023
The EC has granted approval for Merck’s Keytruda regimen for gastric or gastroesophageal junction (GEJ) adenocarcinoma.
The Script
AUGUST 30, 2023
Are you a pharmacy professional? Discover your alternative work settings with the help of our experts at Rx relief.
Outsourcing Pharma
AUGUST 30, 2023
With more than 63 biopharma companies attending and 15 event partners sharing solutions, the 7th Annual IPF Summit being held in Boston next month (September 2023) is not to be missed.
Pharmaceutical Technology
AUGUST 30, 2023
Shares in the company tanked 80% following the FDA issued a CRL for its bevacizumab formulation.
Drug Patent Watch
AUGUST 30, 2023
Annual Drug Patent Expirations for COSELA Cosela is a drug marketed by G1 Therap and is included in one NDA. It is available from one supplier. There are eleven patents… The post New patent for G1 Therap drug COSELA appeared first on DrugPatentWatch - Make Better Decisions.
The Pharmacist
AUGUST 30, 2023
Independent prescribers can learn how to supervise prescribing training through a funded programme launching in England next month. There are 500 places available for pharmacy staff to train as Designated Prescribing Practitioners (DPPs), with a further 500 places to support other educational supervisors, including Designated Supervisors (DSs) and Pre-registration Trainee Pharmacy Technician education supervisors.
Drug Patent Watch
AUGUST 30, 2023
Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are one hundred and… The post New patent for Axsome drug AUVELITY appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
AUGUST 30, 2023
Keytruda gets front-line gastric cancer okay in EU Phil.
Drug Patent Watch
AUGUST 30, 2023
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are seven patents protecting… The post New patent for Abbvie drug ORILISSA appeared first on DrugPatentWatch - Make Better Decisions.
BioPharma Dive
AUGUST 30, 2023
I2o Therapeutics, now led by former Intarcia head Kurt Graves, licensed the diabetes treatment Intarcia has spent more than a decade developing.
The Guardian - Pharmaceutical Industry
AUGUST 30, 2023
Johnson & Johnson’s year-long deal on life-saving drug bedaquiline is seen as critical move in campaign against disease The cost of a crucial tuberculosis treatment has been halved after an agreement was made to allow the sale of generic versions of the drug. Johnson & Johnson’s price for bedaquiline, considered the backbone of treatment for drug-resistant TB will drop from $289 (£227) to $130 for a six-month course until December 2024.
Expert insights. Personalized for you.
348 
Let's personalize your content